Trial Profile

A Single Dose Clinical Trial to Study the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK1006.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 10 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MK 1006 (Primary)
Indications Type 2 diabetes mellitus
Focus Adverse reactions
Sponsors Merck Sharp & Dohme Corp.

Most Recent Events

07 Apr 2009 Patient numbers amended from 24 to 16 as reported by ClinicalTrials.gov.
07 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
07 Apr 2009 Actual initiation date changed from May 2008 to Apr 2008 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com